![Kristian Humer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristian Humer
Directeur Financier/CFO chez
4D MOLECULAR THERAPEUTICS, INC.
Fortune : 12 149 $ au 31/07/2026
Profil
Kristian Franz Humer is currently an Independent Director at Faeth Therapeutics, Inc. since 2021 and Chief Financial & Accounting Officer at 4D Molecular Therapeutics, Inc. starting in 2026.
Former roles include Chief Financial, Accounting & Business Officer at Viridian Therapeutics, Inc. from 2021 to 2023; Chief Financial Officer at Foghorn Therapeutics, Inc. from 2024 to 2025; Managing Director at Citigroup Global Markets, Inc. (Broker) from 2016 to 2021; MD-Global Healthcare Banking & Capital Markets at Citigroup, Inc. from 2017 to 2021; Associate Director at UBS Financial Services, Inc. from 2004 to 2006; Vice President at Nomura Asset Management USA, Inc. from 2008 to 2009; Associate at Lehman Brothers Holdings, Inc. (Investment Portfolio) from 2007 to 2008; Associate at Merrill Lynch Ventures LLC from 1998 to 2001.
Education includes an undergraduate degree from The University of Reading in 1998 and an MBA from The Fuqua School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 446 ( 0 % ) | 12 149 $ | 31/07/2026 |
Postes actifs de Kristian Humer
| Sociétés | Poste | Début |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Directeur/Membre du Conseil | 30/07/2021 |
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur Financier/CFO | 17/11/2025 |
Anciens postes connus de Kristian Humer
| Sociétés | Poste | Fin |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur Financier/CFO | 14/11/2025 |
| VIRIDIAN THERAPEUTICS, INC. | Directeur Financier/CFO | 12/09/2023 |
Citigroup Global Markets, Inc. (Broker)
 Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/07/2021 |
| CITIGROUP INC. | Corporate Officer/Principal | 01/07/2021 |
Nomura Asset Management USA, Inc.
 Nomura Asset Management USA, Inc. Investment ManagersFinance NAM-USA offers several long only global and international equity strategies. Affiliated sub-advisers manage, on a discretionary basis, all the firm’s global and international equity portfolios. The sub-advisers utilize an investment approach that combines a top-down and bottom-up analysis, with a bias towards bottom-up stock selection. All such sub-advisers use a team approach with a focus on country and/or sector analysis. | Corporate Officer/Principal | 01/12/2009 |
Formation de Kristian Humer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
UBS Financial Services, Inc.
 UBS Financial Services, Inc. Investment ManagersFinance UBS Financial Services' asset allocations are based on a proprietary methodology. In developing those allocations, the firm considers asset class risk and return results that are based on estimated forward-looking return and risk assumptions, as measured by standard deviation, which are based on UBS proprietary research. The development process includes a review of a variety of factors, including the return, risk, correlations and historical performance of various asset classes, inflation and risk premium. | Finance |
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
Nomura Asset Management USA, Inc.
Nomura Asset Management USA, Inc. Investment ManagersFinance NAM-USA offers several long only global and international equity strategies. Affiliated sub-advisers manage, on a discretionary basis, all the firm’s global and international equity portfolios. The sub-advisers utilize an investment approach that combines a top-down and bottom-up analysis, with a bias towards bottom-up stock selection. All such sub-advisers use a team approach with a focus on country and/or sector analysis. | Finance |
Citigroup Global Markets, Inc. (Broker)
Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Merrill Lynch Ventures LLC
 Merrill Lynch Ventures LLC Investment ManagersFinance Merrill Lynch Ventures invests in companies located in the United States. The firm focuses across a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
The University of Reading
 The University of Reading Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehman Brothers Holdings, Inc. (Investment Portfolio)
 Lehman Brothers Holdings, Inc. (Investment Portfolio) Financial ConglomeratesFinance Profile Unavailable | Finance |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Viridian Therapeutics, Inc.
 Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
